Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
507-03-009 ISMRM Abstract

Towards Reliable CEST Imaging of the Breast: Evaluation of Fat Correction Strategies at 3T

Accepted
Neele Kempa 1,2, Petr Menshchikov1, Mark E Ladd1,2,3, Peter Bachert1,2, Andreas Korzowski1, Philip S Boyd1
1Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
2Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany
3Faculty of Medicine, Heidelberg University, Heidelberg, Germany
Presenting Author: Neele Kempa

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. McMahon MT, Gilad AA, Bulte JWM, van Zijl PCM. Chemical Exchange Saturation Transfer Imaging: Advances and Applications. 1st ed. Singapore: Pan Stanford Publishing Pte Ltd; 2017. doi:10.1201/9781315364421 [doi]
2. van Zijl PCM, Yadav NN. Chemical exchange saturation transfer (CEST): What is in a name and what isn’t? Magn. Reson. Med. 2011;65:927–948. doi: 10.1002/mrm.22761, PMID: 21337419 [doi] [pmid]
3. Zaiss M, Bachert P. Chemical exchange saturation transfer (CEST) and MR Z-spectroscopy in vivo: a review of theoretical approaches and methods. Phys. Med. Biol. 2013;58:R221–R269. doi:10.1088/0031-9155/58/22/R221, PMID: 24201125 [doi] [pmid]
4. Togao O, Yoshiura T, Keupp J, et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro-Oncol. 2014;16:441–448. doi:10.1093/neuonc/not158, PMID: 24305718 [doi] [pmid]
5. Zhou J, Tryggestad E, Wen Z, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat. Med. 2011;17:130–134. doi:10.1038/nm.2268, PMID: 21170048 [doi] [pmid]
6. Kroh F, von Knebel Doeberitz N, Breitling J, et al. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy. Magn. Reson. Med. 2023;90:1569–1581. doi:10.1002/mrm.29746, PMID: 37317562 [doi] [pmid]
7. Knebel Doeberitz NV, Kroh F, Breitling J, et al. CEST Imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2023:109694. doi:10.1016/j.radonc.2023.109694, PMID: 37150450 [doi] [pmid]
8. Lu J, Zhou J, Cai C, Cai S, Chen Z. Observation of true and pseudo NOE signals using CEST-MRI and CEST-MRS sequences with and without lipid suppression. Magn. Reson. Med. 2015;73:1615–1622. doi:10.1002/mrm.25277, PMID: 24803172 [doi] [pmid]
9. Vinogradov E, Keupp J, Dimitrov IE, Seiler S, Pedrosa I. CEST-MRI for body oncologic imaging: are we there yet? NMR Biomed. 2023;36:e4906. doi:10.1002/nbm.4906, PMID: 36640112 [doi] [pmid]
10. Kempa N, Boyd PS, Menshchikov P, Ladd ME, Bachert P, Korzowski A. Comparison of Fat Correction Methods in CEST Imaging: A Phantom Study at 3 T. Proc. 34th Annu. Meet. Int. Soc. Magn. Reson. Med. 2025;(2025) Abstract #4760.
11. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189–194. doi:10.1148/radiology.153.1.6089263, PMID: 6089263 [doi] [pmid]
12. Reeder SB, Pineda AR, Wen Z, et al. Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): Application with fast spin-echo imaging. Magn. Reson. Med. 2005;54:636–644. doi:10.1002/mrm.20624, PMID: 16092103 [doi] [pmid]
13. Zimmermann F, Korzowski A, Breitling J, et al. A novel normalization for amide proton transfer CEST MRI to correct for fat signal–induced artifacts: application to human breast cancer imaging. Magn. Reson. Med. 2020;83:920–934. doi:10.1002/mrm.27983, PMID: 31532006 [doi] [pmid]
14. Zaiss M, Ehses P, Scheffler K. Snapshot-CEST: Optimizing spiral-centric-reordered gradient echo acquisition for fast and robust 3D CEST MRI at 9.4 T. NMR Biomed. 2018;31:e3879. doi:10.1002/nbm.3879, PMID: 29372571 [doi] [pmid]
15. Meissner J-E, Goerke S, Rerich E, et al. Quantitative pulsed CEST-MRI using Ω-plots. NMR Biomed. 2015;28:1196–1208. doi:10.1002/nbm.3362, PMID: 26278686 [doi] [pmid]
16. Schuenke P, Windschuh J, Roeloffs V, Ladd ME, Bachert P, Zaiss M. Simultaneous Mapping of Water Shift and B1 (WASABI)—Application to Field-Inhomogeneity Correction of CEST MRI Data. Magn. Reson. Med. 2017;77:571–580. doi:10.1002/mrm.26133, PMID: 26857219 [doi] [pmid]
17. Windschuh J, Zaiss M, Meissner J-E, et al. Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at 7 T. NMR Biomed. 2015;28:529–537. doi:10.1002/nbm.3283, PMID: 25788155 [doi] [pmid]
18. Zaiß M, Schmitt B, Bachert P. Quantitative separation of CEST effect from magnetization transfer and spillover effects by Lorentzian-line-fit analysis of z-spectra. J. Magn. Reson. 2011;211:149–155. doi:10.1016/j.jmr.2011.05.001, PMID: 21641247 [doi] [pmid]
19. Goerke S, Soehngen Y, Deshmane A, et al. Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T. Magn. Reson. Med. 2019;82:622–632. doi:10.1002/mrm.27751, PMID: 30927313 [doi] [pmid]
20. Zaiss M, Xu J, Goerke S, et al. Inverse Z-spectrum analysis for spillover-, MT-, and T1-corrected steady-state pulsed CEST-MRI – application to pH-weighted MRI of acute stroke. NMR Biomed. 2014;27:240–252. doi:10.1002/nbm.3054, PMID: 24395553 [doi] [pmid]
21. Reeder SB, Wen Z, Yu H, et al. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn. Reson. Med. 2004;51:35–45. doi:10.1002/mrm.10675, PMID: 14705043 [doi] [pmid]
22. Boyd PS, Menshchikov P, Loi L, et al. Unlocking the rNOE-CEST Contrast for Breast Cancer MRI Using the FATLESS Approach. Invest. Radiol. 2025. doi:10.1097/RLI.0000000000001222, PMID: 40690311 [doi] [pmid]

Cite this abstract